Oramed Pharmaceuticals, Inc.
(NASDAQ : ORMP)

( )
ORMP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -2.07%53.490.0%$435.88m
HZNPHorizon Therapeutics Plc 1.65%103.765.4%$197.51m
CTLTCatalent, Inc. -3.95%128.672.0%$140.45m
VRXValeant Pharmaceuticals International, Inc. -4.49%23.8314.1%$140.22m
ICLRICON plc -2.03%270.472.8%$113.03m
UTHRUnited Therapeutics Corp. -2.32%189.5013.9%$79.26m
JAZZJazz Pharmaceuticals Plc -2.08%119.872.1%$71.81m
BHCBausch Health Cos., Inc. -4.49%23.830.0%$71.24m
PRGOPerrigo Co. Plc -2.05%36.716.9%$55.85m
CPIXCumberland Pharmaceuticals, Inc. 128.64%5.030.6%$53.21m
ARGXargenx SE 1.05%279.210.0%$53.10m
ENDPEndo International Plc -4.11%5.608.5%$51.98m
QLGNQualigen Therapeutics, Inc. -6.96%1.470.0%$27.60m
AXSMAxsome Therapeutics, Inc. 0.58%34.541.8%$24.89m
IRWDIronwood Pharmaceuticals, Inc. 2.12%11.099.5%$24.26m

Company Profile

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.